[A new, more expensive agent against ovarian cancer. Worth its price?]

MeSH terms

• Antineoplastic Agents, Phytogenic / economics
• Antineoplastic Agents, Phytogenic / therapeutic use*
• Cost of Illness
• Cost-Benefit Analysis
• Drug Costs
• Female
• Humans
• Ovarian Neoplasms / drug therapy*
• Ovarian Neoplasms / economics
• Ovarian Neoplasms / psychology
• Paclitaxel / economics
• Paclitaxel / therapeutic use*
• Quality of Life
• Sweden